Acute chest pain (ACP) is a common symptom that can be indicative of a wide range of clinical conditions, some of which are life-threatening. This article aims to provide a comprehensive guide to the clinical approach for healthcare professionals encountering patients with ACP.
On encountering a patient with ACP, the first step is to conduct a rapid assessment to rule out life-threatening conditions such as myocardial infarction or aortic dissection. This includes a thorough history, physical examination, electrocardiogram (ECG), and cardiac biomarkers.
ACP can be cardiac or non-cardiac in origin. Cardiac causes include acute coronary syndromes (ACS), pericarditis, and myocarditis. Non-cardiac causes range from gastrointestinal conditions, such as gastroesophageal reflux disease (GERD) and peptic ulcer disease, to pulmonary conditions, such as pneumonia and pulmonary embolism. A thorough differential diagnosis is crucial to guide further investigations and management.
Further investigations are guided by the initial assessment and differential diagnosis. These may include imaging studies, stress testing, or invasive procedures like coronary angiography. Management will depend on the underlying cause and may range from medical therapy to surgical intervention. In all cases, patient education about lifestyle modifications and risk factor management is essential.
Patients with ACP should be closely followed up to monitor their response to treatment and adjust management as necessary. Primary and secondary prevention strategies, including lifestyle modifications and pharmacotherapy, play a crucial role in preventing recurrence of ACP and associated complications.
ACP is a common but potentially serious symptom that necessitates a systematic and comprehensive clinical approach. Rapid initial assessment, thorough differential diagnosis, appropriate investigations, targeted management, and diligent follow-up are essential to ensure optimal patient outcomes.
1.
A US health panel advises starting mammograms at age 40 rather than 50.
2.
TULSA Is Effective in Long-Term Prostate Cancer Control.
3.
J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79
4.
In Sickle Cell Disease, Lovo-Cel is "Life-Changing, Transformative.".
5.
How Social Determinants of Health Are Linked to Outcomes in Multiple Myeloma
1.
Molecular Matching for Individualized Blood-Disorder Therapy
2.
Everything You Need To Know About Melanoma Choroid: Causes, Symptoms, and Treatment
3.
Drug Safety Surveillance of Long-Term Medication Effects in Cancer Survivorship
4.
HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment
5.
Early Diagnosis of Lung Cancer Through Emerging Biomarkers
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Current Scenario of Cancer- The Incidence of Cancer in Men
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
4.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation